Journal of Chromatography B, 879 (2011) 3214–3219
Contents lists available at ScienceDirect
Journal of Chromatography B
jo u r n al hom epage: www.elsevier.com/locate/chromb
Determination of time-dependent accumulation of d-lactate in the
streptozotocin-induced diabetic rat kidney by column-switching HPLC with
fluorescence detection
Mei-Hsiang Lin
a
, Hsiang-Yin Chen
a
, Tzu-Hsin Liao
a
, Tzu-Chuan Huang
a
, Chien-Ming Chen
b
,
Jen-Ai Lee
a,∗
a
School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing St., Taipei 11031, Taiwan
b
Department of Electro-Optical Engineering, National Taipei University of Technology, No. 1, Sec. 3, Chung-Hsiao E. Rd., Taipei 106, Taiwan
a r t i c l e i n f o
Article history:
Received 30 November 2010
Accepted 8 February 2011
Available online 13 February 2011
Keywords:
d-Lactate
l-Lactate
Diabetic rat
Nephropathy
Streptozotocin
Methylglyoxal
a b s t r a c t
For better understanding the complete metabolism and the physiological role of d-lactate, the concen-
trations of d-lactate in the serum, liver and kidney of normal and diabetic rats were determined by
our established column-switching HPLC method with pre-column fluorescence derivatization. Eight-
week-old male Sprague–Dawley rats were administered with streptozotocin (STZ) (80 mg/kg) or citrate
buffer intraperitoneally. The tissues were then removed and homogenized after 4, 8, 12 and 16 weeks
of drug administration, respectively. The homogenates were centrifuged at 1200 × g for 10 min, then the
supernatants were derivatized with a fluorescent reagent, 4-nitro-7-piperazino-2,1,3-benzoxadiazole
(NBD-PZ), separated on an ODS column followed by a Chiralpak AD-RH chiral column for enantiosep-
aration. The results showed that the d-lactate content elevated in all the 3 examined tissues under
diabetic stages. In addition, d-lactate concentrations in rat kidney were accumulated significantly and
time-dependently in diabetic groups after receiving STZ for 4, 8, 12 and 16 weeks (2.99, 13.11, 18.19,
23.23 vs. 0.79 mol/mg protein as control group). Moreover, the kidney of induced 12-week diabetic rat
renal showed some histological changes of progressive diabetic nephropathy. The results suggest that
d-lactate may be used as a marker of diabetic nephropathy.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
The d-lactate, an endogenous product from excessive use of reg-
ular energy resources, has been tested to use as a marker of several
diseases. It has reported to increase in bacterial infection [1,2], acute
intestinal ischemia [3–6], and appendicitis [7,8]. The most recent
application is on its relationship with the severity of diabetics. Sig-
nificant increases of serum, plasma and urinary d-lactate under
diabetic stage were found in our previous publications [9–11]. In
diabetic stage, with the catalysis by glyoxalase I and II being the
major producing pathway [12,13], the plasma level of d-lactate
was found to elevate proportionally with the increasing production
Abbreviations: DM, diabetes mellitus; TFA, trifluoroacetic acid; NBD-
PZ, 4-nitro-7-piperazino-2,1,3-benzoxadiazole; I.S., internal standard; o-PD,
o-phenylenediamine; 2-MQ, 2-methylquinoxaline; 5-MQ, 5-methylquinoxaline;
AGEs, advanced glycation end products.
This paper is part of the special issue “Analysis and Biological Relevance of d-
Amino Acids and Related Compounds”, Kenji Hamase (Guest Editor).
∗
Corresponding author. Tel.: +886 2 2736 1661x6125;
fax: +886 2 2736 1661x6120.
E-mail address: jenai@tmu.edu.tw (J.-A. Lee).
of its precursor, methylglyoxal (MG), in plasma [14–17]. However,
the concentrations of d-lactate and MG in other biological sam-
ples at normal and diabetic stage are warranted to determine for
establishing the model of application in diabetes.
Measuring the concentrations of d-lactate in biological sam-
ples encounters many barriers. Lactic acid (2-hydroxypropionic
acid), the chemical formula of C
3
H
6
O
3
, has a chiral center to form
two enantiomers, l-(+)-lactic acid and d-(-)-lactic acid. With a
pK
a
value of 3.86, lactic acid mostly dissolves to form lactate in
the physiological fluids. The automated metabolite analyzers can
only determine the content of l-lactate by using l-lactate dehy-
drogenase. And the traditional enzymatic method by d-lactate
dehydrogenase (d-LDH), although widely used to measure d-
lactate in biological samples, cross reacts with many endogenous
substances, such as pyruvate, S-lactonyl glutathione, l-lactate,
fructose 1,6-bisphosphate, and 3-phosphoglyceric acid, reducing
its accuracy and precision significantly [18,19]. To overcome the
above drawbacks, many high-performance liquid chromatography
(HPLC) methods have been developed and modified by our pre-
vious efforts [9,20]. We previously determined the d-lactate in
urine of normal and diabetic rats by HPLC with an octadecylsil-
ica (ODS) column connected to an amylose-based chiral column.
1570-0232/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.jchromb.2011.02.015